YS Biopharma Co (YS Biopharma Co) Days Inventory : 715.40 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is YS Biopharma Co Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). YS Biopharma Co's Average Total Inventories for the six months ended in Sep. 2023 was $28.03 Mil. YS Biopharma Co's Cost of Goods Sold for the six months ended in Sep. 2023 was $7.15 Mil. Hence, YS Biopharma Co's Days Inventory for the six months ended in Sep. 2023 was 715.40.

The historical rank and industry rank for YS Biopharma Co's Days Inventory or its related term are showing as below:

YS' s Days Inventory Range Over the Past 10 Years
Min: 383.3 Med: 435.8 Max: 608.72
Current: 608.72

During the past 3 years, YS Biopharma Co's highest Days Inventory was 608.72. The lowest was 383.30. And the median was 435.80.

YS's Days Inventory is ranked worse than
84.53% of 653 companies
in the Biotechnology industry
Industry Median: 190.92 vs YS: 608.72

YS Biopharma Co's Days Inventory increased from Sep. 2022 (336.83) to Sep. 2023 (715.40). It might indicate that YS Biopharma Co's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. YS Biopharma Co's Inventory Turnover for the six months ended in Sep. 2023 was 0.26.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. YS Biopharma Co's Inventory-to-Revenue for the six months ended in Sep. 2023 was 0.75.

YS Biopharma Co Days Inventory Historical Data

The historical data trend for YS Biopharma Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YS Biopharma Co Days Inventory Chart

YS Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Days Inventory

498.25

383.30

435.80

YS Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Days Inventory	Get a 7-Day Free Trial			231.72	568.36	336.83	526.26	715.40

Competitive Comparison of YS Biopharma Co's Days Inventory

For the Biotechnology subindustry, YS Biopharma Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YS Biopharma Co's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, YS Biopharma Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where YS Biopharma Co's Days Inventory falls into.

YS Biopharma Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

YS Biopharma Co's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

	Days Inventory (A: Mar. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2022 )	+	Total Inventories (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (26.244	+	26.902)	/	2 )	/	22.256	*	365
=	26.573					/	22.256	*	365
=	435.80

YS Biopharma Co's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

	Days Inventory (Q: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2023 )	+	Total Inventories (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (26.902	+	29.162)	/	2 )	/	7.151	*	365 / 2
=	28.032					/	7.151	*	365 / 2
=	715.40

YS Biopharma Co (NAS:YS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

YS Biopharma Co's Inventory Turnover for the six months ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	7.151	/	28.032
	=	0.26

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

YS Biopharma Co's Inventory to Revenue for the six months ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	28.032	/	37.421
	=	0.75

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

YS Biopharma Co Days Inventory Related Terms

Thank you for viewing the detailed overview of YS Biopharma Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

YS Biopharma Co (YS Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » YS Biopharma Co Ltd (NAS:YS) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.